Previous 10 | Next 10 |
Amedisys (AMED): Q3 Non-GAAP EPS of $2.24 beats by $0.97; GAAP EPS of $2.16 beats by $0.92.Revenue of $544.07M (+10.0% Y/Y) beats by $11.14M.Press Release For further details see: Amedisys EPS beats by $0.97, beats on revenue
BATON ROUGE, La., Oct. 28, 2020 (GLOBE NEWSWIRE) -- Amedisys, Inc. (NASDAQ: AMED) today reported its financial results for the three and nine-month periods ended September 30, 2020. Three-Month Periods Ended September 30, 2020 and 2019 Net service revenue increased...
Amedisys (NASDAQ:AMED) is scheduled to announce Q3 earnings results on Wednesday, October 28th, after market close.The consensus EPS Estimate is $1.27 (+10.4% Y/Y) and the consensus Revenue Estimate is $532.93M (+7.7% Y/Y).Over the last 2 years, AMED has beaten EPS estimates 100% of the...
Welcome to Seeking Alpha's Stocks to Watch - a preview of key events scheduled for the next week. Follow this account and turn the e-mail alert on to receive this article in your inbox every Saturday morning. A podcast of Stocks to Watch is also available on Sundays on Seeking Alpha , Apple ...
BATON ROUGE, La., Aug. 31, 2020 (GLOBE NEWSWIRE) -- Amedisys, Inc. (NASDAQ: AMED), one of America's leading home health, hospice and personal care companies, today announced that Paul B. Kusserow, President and Chief Executive Officer will present at the Baird 2020 Global Healthcare Confere...
Amedisys (NASDAQ: AMED ) signed a Care Coordination Agreement with BrightStar Care in order to add its agencies to the Amedisys Personal Care Network and facilitate the coordination of care between the former's hospice and home health care centers and personal care partners network. Mo...
BATON ROUGE, La., Aug. 24, 2020 (GLOBE NEWSWIRE) -- Amedisys, Inc. (NASDAQ: AMED), America’s leading independent home health, hospice and personal care company, has signed a Care Coordination Agreement with BrightStar Care to add its agencies to the Amedisys Personal Care Network, wh...
Amedisys, Inc. (AMED) Q2 2020 Earnings Conference Call July 29, 2020 11:00 AM ET Company Participants Nick Muscato - Vice President of Strategic Finance Paul Kusserow - President & Chief Executive Officer Scott Ginn - Chief Financial Officer Chris Gerard - Chief Operating O...
Image source: The Motley Fool. AMEDISYS Inc (NASDAQ: AMED) Q2 2020 Earnings Call Jul 29, 2020 , 11:00 a.m. ET Operator Continue reading
The following slide deck was published by Amedisys, Inc. in conjunction with their 2020 Q2 earnings Read more ...
News, Short Squeeze, Breakout and More Instantly...
BATON ROUGE, La., July 24, 2024 (GLOBE NEWSWIRE) -- Amedisys, Inc. (NASDAQ: AMED) today reported its financial results for the three and six-month periods ended June 30, 2024. Three-Month Periods Ended June 30, 2024 and 2023 Net service revenue increased $38.2 million to...
Alkermes plc (ALKS) is expected to report $0.64 for Q2 2024 Acerinox ADR (ANIOY) is expected to report for Q2 2024 Allegion plc (ALLE) is expected to report $1.77 for Q2 2024 Deutsche Bank AG (DB) is expected to report $0.43 for Q2 2024 Pathward Financial Inc. (CASH) is expected t...
Amedisys, Inc. (NASDAQ: AMED) has caught the attention of the investment community today with its bullish price action. The company's shares have moved 3.74% on the day to $95.23. Amedisys, Inc., together with its subsidiaries, provides healthcare services in the United States. It operates thr...